These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4177687)

  • 1. [Coagulation spectrum in coronary sclerosis and infarct].
    Rex J
    Z Gesamte Inn Med; 1968 Apr; 23(7):Suppl:97-8. PubMed ID: 4177687
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the treatment of myocardial infarct with special reference to fibrinolytic substances].
    Heinrich HG
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):38-45. PubMed ID: 4189370
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulants updated--application in coronary artery disease.
    Robinson DS
    Cardiovasc Clin; 1974; 6(2):9-22. PubMed ID: 4613466
    [No Abstract]   [Full Text] [Related]  

  • 4. [New therapeutic trends in myocardial infarct. Preliminary data on long-term treatment with fibrinolytic agents in angiopathic patients].
    Molino N
    Cardiol Prat; 1967 Oct; 18(5):51-7. PubMed ID: 4179097
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood coagulation state and the dynamic function of the thrombocytes in myocardial infarct in the process of heparin therapy].
    Kesler VM
    Zdravookhr Kirg; 1978; (3):8-11. PubMed ID: 27045
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute coronary syndromes: new developments in pharmacological treatment strategies.
    Gylys K; Gold M
    Crit Care Nurse; 2000 Apr; Suppl():3-14; quiz 15-6. PubMed ID: 11876169
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
    Thiele R
    Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thrombodensitographic changes during treatment with a coumarin derivative].
    Ferri F; Regazzini A
    Minerva Med; 1970 Jan; 61(8):309-18. PubMed ID: 4189912
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of fibrinolysin with heparin and thrombolytin on blood coagulation indices in myocardial infarct patients with thromboembolic complications].
    Panchenko VM; Dmitrieva ZA; Pastorova VE
    Ter Arkh; 1971 Aug; 43(8):95-9. PubMed ID: 4261359
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thrombolytic therapy in acute coronary syndrome--Part II].
    Barbash G
    Harefuah; 1989 Feb; 116(4):210-3. PubMed ID: 2659447
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease.
    Goodall AH; Knight C
    N Engl J Med; 1998 Jan; 338(2):130-1. PubMed ID: 9424585
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo assessment of thrombosis and fibrinolysis during acute myocardial infarction.
    Jaffe AS; Eisenberg PR; Wilner GD
    Prog Hematol; 1987; 15():71-89. PubMed ID: 3332392
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current views on anticoagulant and fibrinolytic treatment in coronary arterial disease].
    Wojczuk J
    Wiad Lek; 1971 Apr; 24(8):749-54. PubMed ID: 4252798
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anticoagulants in coronary disease].
    Popescu P
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1976; 28(5):329-34. PubMed ID: 14368
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thrombolytic treatment with streptokinase in recent myocardial infarct].
    Pagnoni D
    Cardiol Prat; 1970 Dec; 21(6):405-9. PubMed ID: 4101064
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of fibrinogen in renal disease. II. Effect of anticoagulants and urokinase on experimental lesions in mice.
    Humair L; Kwaan HC; Potter EV
    J Lab Clin Med; 1969 Jul; 74(1):72-8. PubMed ID: 4182788
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of patients with acute coronary insufficiency with thrombolytic preparations (fibrinolysin and thrombolytin)].
    Khalfen ESh; Orlova NP
    Ter Arkh; 1968 Dec; 40(12):48-52. PubMed ID: 4247402
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fibrinolytics. 46].
    Wagler M
    Pharm Prax; 1970; 6():141-2. PubMed ID: 4195438
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of the duration of coronary occlusion on the healing of an experimental myocardial infarct].
    Syroïd DV; Sokrut VM; Shvyrenko IR
    Fiziol Zh (1994); 1999; 45(6):26-30. PubMed ID: 10687078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond coronary thrombolysis.
    Becker RC; Alpert JS
    Arch Intern Med; 1988 Jul; 148(7):1503-7. PubMed ID: 3382294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.